Search - tctmd.com

Displaying 1 - 20 of 58

Sort: Relevancy | Date

News Daily News

Both Low-fat and Low-carb Diets Tied to Less Heart Disease

Michael O'Riordan

February 11, 2026

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for January 2026

Caitlin E. Cox

February 02, 2026

News Daily News

Heart Disease Remains Number One Killer of Americans

L.A. McKeown

January 22, 2026

News Daily News

Weight Regained Within 18 Months of Stopping GLP-1 Drugs

Michael O'Riordan

January 08, 2026

News Daily News

SURPASS-CVOT Published: Large Trial Confirms CVD Efficacy of Tirzepatide

Michael O'Riordan

December 18, 2025

News Daily News

CVD Still the Leading Cause of Death and Disease Globally

Michael O'Riordan

September 24, 2025

News Daily News

Body Fat Distribution Influences Cardiovascular Age

Todd Neale

August 22, 2025

News Daily News

Oral GLP-1 Drug Yields 12% Weight Loss in Nondiabetic Patients With Obesity

L.A. McKeown

August 07, 2025

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for July 2025

Caitlin E. Cox

July 31, 2025

News Daily News

PRAGUE-25: Ablation Improves Rhythm Control, but Don’t Discount Lifestyle Changes

Todd Neale

July 14, 2025

App-Based Support Aids Weight Loss With Semaglutide, Studies Show

Michael O'Riordan

May 13, 2025

News Conference News European Congress on Obesity 2025

Tirzepatide Tops Semaglutide for Weight Loss: SURMOUNT-5

Michael O'Riordan

May 12, 2025

News Daily News

Oral GLP-1 Drug Shines in Phase III ACHIEVE-1 Trial, Lilly Says

Caitlin E. Cox

April 17, 2025

News Daily News

Newer Weight-Loss Drugs Not Cost-effective at Current Prices

Michael O'Riordan

March 18, 2025

News Daily News

Top General Cardiology and Prevention News of 2024

Caitlin E. Cox

December 30, 2024

News Features

Can ‘Body Roundness Index’ Replace BMI? That Depends, Say Experts

Michael O'Riordan

October 21, 2024

News Daily News

Liraglutide Helps Shed Weight in Young Children With Obesity

Todd Neale

September 13, 2024

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for August 2024

Caitlin E. Cox

September 03, 2024

News Daily News

‘Disproportionate’ Suicide/Self-Harm Signal With Semaglutide: WHO Database

Michael O'Riordan

August 21, 2024

News Daily News

SUMMIT Meets Primary Endpoint for Safety, Efficacy of Tirzepatide: Topline Results

Yael L. Maxwell

August 01, 2024

Advertisement

Both Low-fat and Low-carb Diets Tied to Less Heart Disease

TCTMD’s Top 10 Most Popular Stories for January 2026

Heart Disease Remains Number One Killer of Americans

Weight Regained Within 18 Months of Stopping GLP-1 Drugs

SURPASS-CVOT Published: Large Trial Confirms CVD Efficacy of Tirzepatide

CVD Still the Leading Cause of Death and Disease Globally

Body Fat Distribution Influences Cardiovascular Age

Oral GLP-1 Drug Yields 12% Weight Loss in Nondiabetic Patients With Obesity

TCTMD’s Top 10 Most Popular Stories for July 2025

PRAGUE-25: Ablation Improves Rhythm Control, but Don’t Discount Lifestyle Changes

App-Based Support Aids Weight Loss With Semaglutide, Studies Show

Tirzepatide Tops Semaglutide for Weight Loss: SURMOUNT-5

Oral GLP-1 Drug Shines in Phase III ACHIEVE-1 Trial, Lilly Says

Newer Weight-Loss Drugs Not Cost-effective at Current Prices

Top General Cardiology and Prevention News of 2024

Can ‘Body Roundness Index’ Replace BMI? That Depends, Say Experts

Liraglutide Helps Shed Weight in Young Children With Obesity

TCTMD’s Top 10 Most Popular Stories for August 2024

‘Disproportionate’ Suicide/Self-Harm Signal With Semaglutide: WHO Database

SUMMIT Meets Primary Endpoint for Safety, Efficacy of Tirzepatide: Topline Results

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content